PF679 REAL‐WORLD SAFETY DATA FROM A NONINTERVENTIONAL LONG‐TERM POSTAUTHORIZATION SAFETY STUDY OF RUXOLITINIB IN MYELOFIBROSISFiorenza Barraco, Heinz Gisslinger, Raoul Herbrecht et al.|HemaSphere|2019Cited by 0